SE9601219D0 - Pharmaceutical preparation for the treatment of gastritis, reflux oesophagitis, duodenitis, dyspepsia and ulcer disease - Google Patents

Pharmaceutical preparation for the treatment of gastritis, reflux oesophagitis, duodenitis, dyspepsia and ulcer disease

Info

Publication number
SE9601219D0
SE9601219D0 SE9601219A SE9601219A SE9601219D0 SE 9601219 D0 SE9601219 D0 SE 9601219D0 SE 9601219 A SE9601219 A SE 9601219A SE 9601219 A SE9601219 A SE 9601219A SE 9601219 D0 SE9601219 D0 SE 9601219D0
Authority
SE
Sweden
Prior art keywords
alginate
duodenitis
dyspepsia
gastritis
treatment
Prior art date
Application number
SE9601219A
Other languages
English (en)
Other versions
SE9601219L (sv
SE507682C2 (sv
Inventor
Marcin Krotkiewski
Original Assignee
Marcin Krotkiewski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marcin Krotkiewski filed Critical Marcin Krotkiewski
Priority to SE9601219A priority Critical patent/SE507682C2/sv
Publication of SE9601219D0 publication Critical patent/SE9601219D0/sv
Priority to ES97916696T priority patent/ES2184081T3/es
Priority to DE69715625T priority patent/DE69715625T2/de
Priority to AU25253/97A priority patent/AU2525397A/en
Priority to PL97329152A priority patent/PL329152A1/xx
Priority to RU98119709/14A priority patent/RU2193407C2/ru
Priority to PCT/SE1997/000544 priority patent/WO1997036599A1/en
Priority to AT97916696T priority patent/ATE224197T1/de
Priority to EP97916696A priority patent/EP0910388B1/en
Priority to JP9535200A priority patent/JP2000507572A/ja
Publication of SE9601219L publication Critical patent/SE9601219L/sv
Publication of SE507682C2 publication Critical patent/SE507682C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE9601219A 1996-03-29 1996-03-29 Farmaceutisk beredning för behandling av gastrit, refluxesofagit, duodenit, dyspepsi och magsårssjukdom innehållande en blandning av ammoniumvismutcitrat och ett alginat SE507682C2 (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE9601219A SE507682C2 (sv) 1996-03-29 1996-03-29 Farmaceutisk beredning för behandling av gastrit, refluxesofagit, duodenit, dyspepsi och magsårssjukdom innehållande en blandning av ammoniumvismutcitrat och ett alginat
JP9535200A JP2000507572A (ja) 1996-03-29 1997-03-27 胃炎、逆流食道炎、十二指腸炎、消化不良および潰瘍の治療用調合薬品
PL97329152A PL329152A1 (en) 1996-03-29 1997-03-27 Pharmaceutic preparation for treating gastritis, refluxive oesophagitis, duodenitis, indigestion and chronic peptic ulcer disease
DE69715625T DE69715625T2 (de) 1996-03-29 1997-03-27 Arzneipräparat zur behandlung der gastritis, der reflux-ösophagitis, duodenitis,dyspepsie und ulkuserkrankungen
AU25253/97A AU2525397A (en) 1996-03-29 1997-03-27 Pharmaceutical preparation for the treatment of gastritis, reflux oesophagitis, duodenitis, dyspepsia and ulcer disease
ES97916696T ES2184081T3 (es) 1996-03-29 1997-03-27 Preparacion farmaceutica para el tratamiento de la gastritis, de la esofagitis por reflujo, de la duodenitis, de la dispepsia y de la ulcera.
RU98119709/14A RU2193407C2 (ru) 1996-03-29 1997-03-27 Фармацевтические препараты для лечения гастритов, рефлюкс-эзофагитов, дуоденитов, диспепсии и язвы
PCT/SE1997/000544 WO1997036599A1 (en) 1996-03-29 1997-03-27 Pharmaceutical preparation for the treatment of gastritis, reflux oesophagitis, duodenitis, dyspepsia and ulcer disease
AT97916696T ATE224197T1 (de) 1996-03-29 1997-03-27 Arzneipräparat zur behandlung der gastritis, der reflux-ösophagitis, duodenitis,dyspepsie und ulkuserkrankungen
EP97916696A EP0910388B1 (en) 1996-03-29 1997-03-27 Pharmaceutical preparation for the treatment of gastritis, reflux oesophagitis, duodenitis, dyspepsia and ulcer disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9601219A SE507682C2 (sv) 1996-03-29 1996-03-29 Farmaceutisk beredning för behandling av gastrit, refluxesofagit, duodenit, dyspepsi och magsårssjukdom innehållande en blandning av ammoniumvismutcitrat och ett alginat

Publications (3)

Publication Number Publication Date
SE9601219D0 true SE9601219D0 (sv) 1996-03-29
SE9601219L SE9601219L (sv) 1997-09-30
SE507682C2 SE507682C2 (sv) 1998-07-06

Family

ID=20402012

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9601219A SE507682C2 (sv) 1996-03-29 1996-03-29 Farmaceutisk beredning för behandling av gastrit, refluxesofagit, duodenit, dyspepsi och magsårssjukdom innehållande en blandning av ammoniumvismutcitrat och ett alginat

Country Status (10)

Country Link
EP (1) EP0910388B1 (sv)
JP (1) JP2000507572A (sv)
AT (1) ATE224197T1 (sv)
AU (1) AU2525397A (sv)
DE (1) DE69715625T2 (sv)
ES (1) ES2184081T3 (sv)
PL (1) PL329152A1 (sv)
RU (1) RU2193407C2 (sv)
SE (1) SE507682C2 (sv)
WO (1) WO1997036599A1 (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9621273D0 (en) 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
GB0012487D0 (en) * 2000-05-24 2000-07-12 Pfylori Limited Use of metal compounds to treat gastrointestinal infections
WO2003043641A1 (en) * 2001-11-19 2003-05-30 Nobel Ilaç Sanayii Ve Ticaret A.S. New pharmaceutical combinations prepared with alginates and biphosphonates in order to prevent gastroesophageal reflux during use of oral biphoshonates
EP1761157A1 (en) * 2004-04-30 2007-03-14 ALTANA Pharma AG Method of classifying gerd
JP2006342085A (ja) * 2005-06-08 2006-12-21 Kao Corp Ｇｉｐ分泌抑制剤
CN102558383B (zh) * 2012-01-10 2014-07-23 中国科学院海洋研究所 一种海藻酸铋及其制备方法和应用
CN104524356A (zh) * 2014-12-11 2015-04-22 吴燕 一种治疗返流性食道炎的中药组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179474B (en) * 1978-02-24 1982-10-28 Laszlo Gyarmati Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
EP0348143A3 (en) * 1988-06-21 1991-03-13 MARION LABORATORIES, INC. (a Delaware corporation) Bismuth derivatives of saccharide phosphates and sulphates
NL9220019A (nl) * 1992-04-10 1994-04-05 Vnii Med Polimerov Farmaceutische samenstelling.
WO1995025521A1 (en) * 1994-03-24 1995-09-28 The Procter & Gamble Company Solid dose forms containing bismuth

Also Published As

Publication number Publication date
EP0910388A1 (en) 1999-04-28
DE69715625T2 (de) 2003-06-12
ATE224197T1 (de) 2002-10-15
ES2184081T3 (es) 2003-04-01
WO1997036599A1 (en) 1997-10-09
EP0910388B1 (en) 2002-09-18
SE9601219L (sv) 1997-09-30
SE507682C2 (sv) 1998-07-06
DE69715625D1 (de) 2002-10-24
AU2525397A (en) 1997-10-22
PL329152A1 (en) 1999-03-15
JP2000507572A (ja) 2000-06-20
RU2193407C2 (ru) 2002-11-27

Similar Documents

Publication Publication Date Title
US4971782A (en) Periodontal composition and method
US4978528A (en) Process for preventing degradation of an anti-bacterial composition
SE9601219D0 (sv) Pharmaceutical preparation for the treatment of gastritis, reflux oesophagitis, duodenitis, dyspepsia and ulcer disease
PT696921E (pt) Composicao veterinaria contendo um inibidor da bomba de protoes
IS5577A (is) Omeprazól örkorn vernduð gegn magasýrum, framleiðsluferli og lyfjasamsetningar
KR101537774B1 (ko) 악취제거제 조성물 및 그 제조방법
HU913010D0 (en) Method for producing inhibitors of calcium ingestion
IT1262993B (it) Complesso di bismuto citrato di ranitidina ed antibiotico, composizione che lo contiene e relativo metodo di produzione ed impiego
RU94042719A (ru) Содержащий psyllium состав питьевых смесей
ATE249812T1 (de) Schäumende antacida-suspensionstabletten
IL68282A0 (en) Stable granular formulation of unstable drugs or food supplements and their preparation
ATE12791T1 (de) Kurzkettige oligosaccharide mit biologischen eigenschaften, verfahren zu ihrer herstellung und ihre verwendungen als arzneimittel.
AP1790A (en) Composition containing paraquat and/or diquat an alginate and an emetic and/or purgative.
RU98119709A (ru) Фармацевтические препараты для лечения гастритов, рефлюксэзофагитов, дуоденитов, диспепсии и язвы
NO961638L (no) Gelatinkapselfyllstoff som kan skumme
TR199800421A2 (xx) Moenomisin grubu antibiyotiklerin bizmut tuzlar�.
PT1250291E (pt) Agente de melhoramento da agua contendo algas coralinas
FR2763947B1 (fr) Produits stabilisants et leurs melanges, composition les contenant et procede les utilisant
JPS57165089A (en) Purification and deodorization of bath water
IT1301969B1 (it) Sucralfato gel secco granulare e poroso procedimento per la suapreparazione, e composizioni farmaceutiche solide che lo contengono
WO2003018597A1 (fr) Poudre comprenant des cristaux de $g(b)-maltose contenant de l'eau, production et utilisation associees
EP3003979A1 (en) Non-oxidizer particles
JPS62280298A (ja) 粉末状漂白剤組成物
JP3158616B2 (ja) 脱酸素剤
JPH04178330A (ja) 抗腫瘍性物質

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 9601219-0

Format of ref document f/p: F